Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Connect Twitter with Market Wire News

ATNM Quote, Trading Chart, Actinium Pharmaceuticals Inc.


home / stock / atnm / atnm quote

$5.63 Last:

2.36% Change Percent:

$5.5 Open:

$5.63 Previous Close:

$5.63 High:

$5.32 Low:

219,625 Volume:

05/27/2022 04:56:09 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

ATNM Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2022-05-275.55.635.635.32219,625
2022-05-265.555.55.74325.45192,178
2022-05-255.575.565.63715.41140,364
2022-05-245.825.575.895.5193178,526
2022-05-236.115.926.115.8362117,572
2022-05-206.126.056.185.77228,990
2022-05-195.926.086.345.92202,675
2022-05-186.176.036.24095.9132,176
2022-05-175.886.26.275.7701260,892
2022-05-165.415.7465.38238,916
2022-05-135.635.755.835.32548,437
2022-05-125.225.515.555.14467,040
2022-05-115.355.155.455.09349,956
2022-05-105.595.385.735.21451,160
2022-05-095.675.525.8155.43416,099
2022-05-065.995.726.15.7260,709
2022-05-056.136.016.16175.87240,256
2022-05-046.46.296.45.98173,061
2022-05-036.046.46.445.87248,091
2022-05-025.96.056.195.8115271,567
Stock Information

Actinium Pharmaceuticals Inc. Company Name:

ATNM Stock Symbol:

NYSE Market:

MENU
ATNM ATNM Quote ATNM Short ATNM News ATNM Articles ATNM Message Board
Get ATNM Alerts

News, Short Squeeze, Breakout and More Instantly...

Connect Twitter with Market Wire News
RECENT ATNM NEWS
  • ATNM - Actinium Pharmaceuticals (ATNM) NobleCon18 Presentation Replay

    Actinium Pharmaceuticals (ATNM) formal corporate presentation from NobleCon18 - Noble Capital Markets 18th Annual Small & Microcap Investor Conference - April 2022. Read More >>

  • ATNM - Actinium Pharmaceuticals, Inc. Announces 82% of Control Arm Patients Did Not Receive a Bone Marrow Transplant by Conventional Means but 100% of Patients who Received Iomab-B, Including Crossover Patients, in the Phase 3 SIERRA Trial Successfully Engrafted

    Actinium Pharmaceuticals, Inc. Announces 82% of Control Arm Patients Did Not Receive a Bone Marrow Transplant by Conventional Means but 100% of Patients who Received Iomab-B, Including Crossover Patients, in the Phase 3 SIERRA Trial Successfully Engrafted at the Transplantation & Cell...

  • ATNM - Actinium Pharmaceuticals, Inc. to Highlight Iomab-B Pivotal Phase 3 SIERRA Trial Data at the Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR

    Actinium Pharmaceuticals, Inc. to Highlight Iomab-B Pivotal Phase 3 SIERRA Trial Data at the Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR Actinium Pharmaceuticals, Inc. to Highlight Iomab-B Pivotal Phase 3 SIERRA Trial Data at the Transplantation &a...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.



Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email [email protected].

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected
Follow @MarketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News